Hany Massarany, President and CEO at GenMark Diagnostics, Inc. (GNMK), sold 8,047 shares at $4.84 ($39K) on 2018-11-20, disclosed to the SEC on 2018-11-26.
Open-market sale of $39k GNMK by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| AXDX | BUY | 2022-02-01 | $66K | — | Filing → |
| AXDX | BUY | 2021-09-28 | $53K | — | Filing → |
| BDSX | BUY | 2020-11-03 | $135K | — | Filing → |